APYX (apyxmedical.com) צמיחת רווח נקי למניה השנה

The stability of Apyx Medical (APYX) is confirmed by the integration of ESG standards into production and the reduction of its carbon footprint, which supports the year-over-year EPS comparison where the 25.00 level records fresh values. The operational base relies on energy-efficient cooling systems and plastic recycling, as well as unique patents for Renuvion plasma systems and a surgeon training program.

This indicator measures the year-over-year dynamics of net earnings per share, determining the pace of business scaling. Monitoring this metric helps avoid purchasing assets at the peak of a cyclical growth phase. The current relative year-over-year earnings per share growth rate is 25.00. For Apyx Medical (APYX), this metric reflects the commercial efficiency of implementing Renuvion minimally invasive technology. The high profitability of aesthetic procedures converts directly into the growth of this fundamental value.